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Human T cells express various isoforms of CD45 (leukocyte common antigen),
which arise from alternate mRNA splicing (1). The mAb UCHLI recognizes a 180
kD molecular mass isoform, CD45RO (2). Recent studies on major two (CD4+ and
CD8+) subpopulations of circulating T cells have suggested that UCHLI identifies
a primed population of T cells that includes memory cells (3). Within CD4+ cells,
the CD45RO population mediates proliferative responses to recall antigens and is
able to support B cell differentiation . A reciprocal population of CD4+ cells, iden-
tified by mAbs to the 205- and 220-kD molecular mass isoforms termed CD45RA,
do not show these capabilities. It has also been shown that the CD45RO population
of CD8 + cells contains precursors exerting memory-dependent cytotoxicity (4).
While the majority ofmature T cellsexpress the TCR-a/0-CD3 complex, a minor
population of blood T cells lacking both CD4 and CD8 bear a distinct TCR com-
posed of y and S subunits. Although the function and the repertoire of TCR-Y/b
remain to be fully defined, it has been shown that blood TCR-7/6' T cells can be
subdivided largely into two nonoverlapping subsets defined by BB3 and 6TCS1 mAb
(5, 6). In this paper we examined the expression of CD45RO by TCR-y/b+ in
healthy children and adults to elucidate some of their biological roles. We will show
here that CD45RO is preferentially expressed on BB3 + subsets among circulating
TCR-,y/6' cells. BB3+ cells appear to represent a population of Ty/b+ cells capable
of responding to some antigens.
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Blood Samples.
￿
Cord blood was collected from the umbilical vein immediately after the
uneventful delivery of full-term newborn babies. Venous blood from healthy infants and chil-
dren ofdifferent ages was obtained afterthe informed parental consent was given. Adult sub-
jects were healthy volunteers between the ages of 25 and 35 yr.
Monoclonal Antibodies.
￿
The mAb UCHLI (IgG2a) against CD45RO (2) was purchased
from Dakopatts a/s (Copenhagen, Denmark). The BB3 mAb (IgGI) specific for humanTCRy
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chain (5) was the kind gift of Dr. L. Moretta (University ofGeneva, Italy). AntiTiyA mAb
(IgG2a), generously provided by Dr. T. Hercend (Institut Gustave-Roussy, Villejuif, France),
recognizes the human TCR--y molecule (6). FITC-conjugated TCRSI mAb (IgGI) (7) and
FITC-conjugated STCSI mAb (IgGI) (8), both of which have been found to be directed to
human TCR6 chains, were obtained from T Cell Sciences (Cambridge, MA). FITC-con-
jugated anti-Leu-3a mAb (IgGI) specific for CD4 was from Becton Dickinson & Co. (Moun-
tain View, CA).
Immunofluorescence Analysis.
￿
Viable mononuclear cells from heparinized blood were iso-
lated on Ficoll/Hypaque gradients (Lymphoprep, Nycomed AS, Oslo, Norway) and stained
with mAb. Two-color staining was performed to evaluate expression of CD45RO by TCR
y/S' cells. The cells were first incubated with UCHL1 or isotype-matched control mouse
IgG, and counterstained with biotinylated rabbit anti-mouse IgG2a antibody (Zymed Labora-
tories, San Francisco, CA), and further with phycoerythrin (PE)-conjugated streptavidin
(Becton Dickinson & Co.). Next, the cellswere stained for determination of TCR-y/S' cells
with FITC-conjugated TCR61, FITC-conjugated 6TCSI, or unconjugated BB3 mAb. For
BB3 staining, the cells were finally treated with FITC-conjugated horse anti-mouse IgGI
antibody (Zymed Laboratories). The labeled cells were analyzed by an Epics C flow cytom-
eter (Coulter Electronics, Inc., Hialeah, FL).
Proliferative Responses.
￿
TCRy/S' cell (TiyA' and STCSI') subsets were isolated using an
Epics C flow cytometer from mononuclear cells stained with the corresponding mAbs as above.
These cells were seeded on flat-bottomed microtiter plates (Corning Glass Works, Corning,
NY) at 5 x 104 cells/well in 0.2 ml ofRPMI 1640 supplemented with 10% AB serum in the
presence of 5 x 103 irradiated adherent monocytes from the same donor. Cultures were
stimulated with 1 p,g/ml of purified protein derivative (PPD; Japan BCG Co., Ltd., Tokyo,
Japan) or 10 ng/ml of anti-CD3 mAb (OKT3 ; Ortho Pharmaceutical Co., Raritan, NJ) for
120 h and were pulsed with 0.5 EtCi of [3H]TdR 12 h before harvesting. As controls, the
similar cultures were carried out for CD45RO' and CD45RO- CD4' cells separated by the
cell sorting.
Results and Discussion
We used TCRSI mAb to examine the frequency of TCRy/S' cells and their ex-
pression of CD45RO, since TCRSI has been shown to detect the whole population
of TCRy/S' cells (6). The appearance of blood TCRy/S' cells was scarce (<0.5%)
at birth, gradually increased with age, and reached the adultvalues in older children
(Table I). On the other hand, the proportions of TCRa/a+ cells with C134 or CD8
in the neonatal blood are similar to those observed in the adult blood (9). Consistent
TABLE I
Frequency of TCR61' Cells and Their Expression of CD45RO in
Peripheral Blood of Different Ages
" Means + SEM.
Age
Newborn
n
6
Percentage of
TCR61' cells
<0.5
Percent CD45RO expression
by TCRSI' cells
ND
0-1 mo 7 1 .5 t 0.2` 72.5 1 4.6
2-3mo 8 1 .9 t 0.3 63.8 t 3 .3
4-11 mo 6 2.3 1 0.4 61 .0 5 .1
1-2 yr 12 2.7 f 0.5 69.6 t 4.0
3-6 yr 14 3.9 t 0.4 72.4 t 3 .5
7-15 yr 16 4.4 t 0.6 69.3 t 3 .1
Adult 12 5.8 t 1 .1 72.4 t 3 .7MIYAWAKI ET AL .
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with the current concept of naive and memory T cells, we observed that the cir-
culating pool of CD4 + and CD8+ cells expressing CD45RO increased as a func-
tion of age (unpublished observations) . In adult subjects, the mean percentages of
CD45RO' cells within CD4+ and CD8+ cells are 35 and 25%, respectively. In
marked contrast to CD4+ andCD8+ cells, expression of CD45RO was observed on
a sizable portion (N70%) of blood TCRy/S+ cells in all donors examined (Table
I) . The remarkable finding was that most TCRy/S+ cells possessed CD45RO on
their surfaces even around 1 mo of life shortly after birth .
We often observed that some of donors exhibited a clear bimodal distribution of
CD45RO expression on TCR-y/6 ` cells (Fig . 1 A) . This suggests the presence of
a small CD45RO- population ofTCRy/S+ cells in blood. The recent availability
of othermAb specific for human TCR-7/6 molecules have allowed to identify two
mutually exclusive subsets defined by BB3 and STCS1 mAbs (5, 6) . In bloodTCR
y/S+ cells, most cells reacts with BB3, whereas a few cells are positive for 6TCS1.
Based on ourobservations, we next asked whether expression ofCD45RO by these
two TCRy/S+ cells might be different from each other. Fig . 1 shows a representa-
tive of two-color immunofluorescence analysis for CD45RO expression by Ty/S+
subsets . Interestingly, a large percentage ofBB3+ cells were considered CD45RO',
whereasCD45RO expression was absent from STCS1+ cells . As presented in Table
II, this was the rule in all of seven subjects studied .
FIGURE 1 .
￿
Two-colorimmuno-
fluorescence analysis ofCD45RO
expression by TCRS1', BB3'
and STCSI ` cells. Contour
maps (A, C, and E) show two-
color staining patterns of lym-
phocytes gated by forwardand
90° light scatters . A second gate
was set to include the whole
populations of TCRS1+ (B),
BB3+ (D) and STCSl+ cells
(F) and 5,000 cells accumulat-
ing within the gate were ana-
lyzed forCD45RO expression,
which are expressed asthehisto-
gram patterns . A vertical dashed
line in the histograms indicates
the negative control .1836
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TABLE II
Expression of CD45RO by TCR-y16' Subsets
Percent CD45RO Expression by
61 .8 ± 8.91
￿
93.2 t 0.71
￿
1 .5 ± 0.31
(7.4 t 2.8)
￿
(5.6 t 1 .2)
￿
(1.7 t 0.5)
CD45RO expression by each TCR--y/6' subset was examined for the blood from adult
subjects.
' Parentheses indicate the proportions of each subset in lymphocytes.
1 Mean + SEM.
Although studies for established clones suggest that all TCR-y/b' cell clones
mediate non-MHC-restricted cytotoxicity (10), theantigen-specificity and immuno-
logical functions ofthese cells remain speculative. On the basis ofthe correlation
between CD45RO expression and memory T cells, it seemed feasible to suppose
that BB3' cells, but not 6TCSI' cells lacking CD45RO, might contain a popula-
tion responding to certain antigens in a similar manner to memory CD4' cells. Pre-
liminary experimentssuggested thatstainingwithBB3 mAbforthe cellsortingresulted
in somewhat enhanced background responses ofisolated cells, indicatingthe activa-
tion ofcorresponding subsets by this antibody (11). It has been demonstrated that
most BB3+ cells are identified by antiTiyA mAbs as well (12). In addition, resting
TiyA cells do not proliferate in response to antiTiyA mAb in the absence ofexoge-
nous IL-2 (13). Thus, we substituted antiTiyA for BB3 to isolate CD45RO' TCR
y/b' subsets. As shown in Table III, both TiyA' and 6TCS1' cells proliferated well
in response to anti-CD3 mAb. In PPD-reactive individuals, appreciable prolifera-
tive responses to PPD, though less than those seen in memory (CD45RO') CD4+
cells, were obtained only from TiyA' cells, but not from UCSI' cells. These results
strongly suggest that a fraction ofTiyA' cells may contribute the immune response
to a nominal antigen. Since95% ofBB3 cells, though not completely identical, coex-
press TiyA antigen (13), we speculate that functional profiles ofTiyA' cells may
represent those ofBB3+ cells. Regarding the antigen-specific response ofTCR-y/b'
cells, it has recently been reported that TCRy/b' clones established from blood
lymphocytes respond to some antigens such as tetanus toxoid or PPD in a MHC-
restricted fashion (14, 15).
Moretta et al. (16) have indicated that BB3' cells express Cyl-encoded TCR--y/b
heterodimers, whereas 6TCS1' cells express Cy2-encoded molecules. BB3' cells
predominate intheperipheralblood, but are very scantily foundin thethymic tissues.
In contrast, BTCSI' cells are enriched in the thymus. Immunohistochemical anal-
ysis have shown that 6TCSI' cells are predominant in intraepithelial lymphocytes
ofthejejunum ascompared with the blood (17). However, the reason for such different
tissue distribution between BB3' and 6TCSI' cells is unknown.
Subjects TCR61 ` Cells BB3' Cells 6TCS1' Cells
NT 50.1 (4.6)' 92 .1 (3 .5) 1 .4(l .6)
NY 84 .5 (6.6) 94.0 (5 .8) ND (<0.5)
TT 82 .6 (6.6) 93.4 (5 .1) 0.9 (0.9)
NK 62.3 (6.2) 97.2 (4.3) 0.8 (0.9)
AY 86.0 (12.0) 91 .6 (11 .2) ND (<0.5)
YH 92.0 (4.5) 92 .0 (1 .2) 2.6 (1 .4)
YK 38.2 (11 .0) 92.0 (7 .8) 1 .7 (3.8)MIYAWAKI ET AL.
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TABLE III
Proliferative Responses of TCR-y/d' and CD4' Subpopulations
by PPD or Anti-CD3 mAb
Each subpopulation was isolated from PPD-reactive adult donors. The cells (5 x 104/well)
were cultured with PPD (1 ug/ml) or anti-CD3 mAb(10ng/ml) in the presence of autologous
irradiated monocytesfor5d. The results indicate the mean [3H]TdRincorporation of tripli-
cate cultures.
In conclusion, the present study showed that the BB3' subset in the peripheral
blood selectively expressed CD45RO, corresponding with their responding capa-
bility to recall antigens. These observations implicate a special role of this subset
in the immune response to many pathogens and infectious agents.
Summary
We examined the developmental profile of TCRy/S + cells with respect to
CD45RO expression. Although total TCRy/S` cells were negligible in the neonatal
blood and increased with advancing age, most blood TCR'r/S+ cells markedly ex-
pressed CD45RO withoutadistinctionofage, probablyreflecting adifferent CD45RO
expression oftwo subsets defined by BB3 and STCSI mAbs. The vast majority of
BB3+ cells expressed CD45RO, whereas expression ofCD45RO was virtually ab-
sent in the STCSI+ population. Functional studies revealed that, while both TCR
y/S+ cell subsets showed CD3-mediated activation, only BB3+ (or TiyA +) cells, but
not STCSI+ cells, appeared to proliferate in response to PPD in PPD-reactive in-
dividuals. The results suggested that the CD45RO' (BB3 + orTiyA+) subset among
blood TCR-y/b+ cells may be mainly involved in the memory or primed compo-
nent of the immune system responding to some foreign antigens.
We thank Dr. L. Moretta for providing BB3 mAb and for Dr. T. Hercend for kind supply
of antiTiyA mAb.
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